申请人:Almirall, S.A.
公开号:EP2457900A1
公开(公告)日:2012-05-30
The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
这项发明涉及一种化合物的公式(I),以及制备这种化合物的方法,以及它们在治疗病理状况或疾病中的应用,这些病理状况或疾病容易通过CRTh2拮抗活性得到改善。